0001140361-22-029892.txt : 20220816
0001140361-22-029892.hdr.sgml : 20220816
20220816173109
ACCESSION NUMBER: 0001140361-22-029892
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220812
FILED AS OF DATE: 20220816
DATE AS OF CHANGE: 20220816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patel Kinnari
CENTRAL INDEX KEY: 0001725929
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36829
FILM NUMBER: 221171212
MAIL ADDRESS:
STREET 1: 430 EAST 29TH STREET
STREET 2: SUITE 1040
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ROCKET PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001281895
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 350 FIFTH AVENUE
STREET 2: SUITE 7530
CITY: NEW YORK
STATE: NY
ZIP: 10118
BUSINESS PHONE: 646-440-9100
MAIL ADDRESS:
STREET 1: 350 FIFTH AVENUE
STREET 2: SUITE 7530
CITY: NEW YORK
STATE: NY
ZIP: 10118
FORMER COMPANY:
FORMER CONFORMED NAME: INOTEK PHARMACEUTICALS CORP
DATE OF NAME CHANGE: 20040226
4
1
form4.xml
FORM 4
X0306
4
2022-08-12
0001281895
ROCKET PHARMACEUTICALS, INC.
RCKT
0001725929
Patel Kinnari
C/O ROCKET PHARMACEUTICALS, INC.
9 CEDARBROOK DRIVE
CRANBURY
NJ
08512
true
See Remarks
Restricted Stock Units
2022-08-12
4
A
0
52489
0
A
Common Stock
52489
52489
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
The restricted stock units will become fully vested on August 12, 2025.
President & Chief Operating Officer
/s/ Martin Wilson, as attorney-in-fact for Kinnari Patel
2022-08-16